HOME ABOUT ▾ library contact order ABOUT NEUROAID ▸ CLINIcal studies ▸ safety profile ▸ Medical Professionals
composition & dosage ▸ Find out if neuroaid is right for you ABOUT NeuroAiD is an oral treatment helping victims of strokes and traumatic brain injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapies and exercises. Exercise and Vascular Disease: Key Findings from a Systematic Review on Secondary Prevention and Quality of Life

??? VASCULAR DISEASE STUDY HIGHLIGHTS – The effects of exercise on secondary prevention and health-related quality of life in people with existing vascular disease: systematic review and meta-analysis of randomised controlled trials by Broderick, Cathryn et al.

This study investigates the effects of exercise on secondary prevention and health-related quality of life in people with existing vascular disease such as stroke and transient ischaemic attack (TIA).

Key Findings:
• Quality-of-Life Gains
Exercise significantly improved health-related quality of life at the end of interventions, as measured by both EQ-5D and SF-36 (moderate-certainty evidence).

• Fewer Hospitalizations
Participants who exercised experienced fewer vascular-related hospital admissions in both short-term and medium-term follow-up.

• No Significant Mortality Benefit
Exercise did not significantly impact all-cause or cardiovascular mortality overall, although there was a trend toward reduced cardiovascular death at long-term follow-up (more than 30 months).

• Data Gap for Polyvascular Patients
Most studies involved patients with a single vascular disease; fewer than half reported on comorbid vascular conditions. Therefore, it’s unclear how much these results apply to individuals with polyvascular disease.

? Access the full article at: Broderick, Cathryn et al. The effects of exercise on secondary prevention and health-related quality of life in people with existing vascular disease: systematic review and meta-analysis of randomised controlled trials. eClinicalMedicine, Volume 83, 103201. https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(25)00133-6/fulltext. This is an open-access article under a CC-BY 4.0 license.